Searched for
IRBESARTAN
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...
- Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%Budget 2026 underlines the government’s intent – in terms of the sectors it will focus on. Now, it is not all of a sudden that the governme...
- Sound businesses are the best antidote for volatility: 6 large- and mid-cap stocks with an upside potential of up to 30%The market hates uncertainty. Post the big reforms (GST and banking), the markets should have ideally been in upbeat mode this festive seas...
- One simple reason to own & trade them: 5 large-caps from different sectors with upside potential of up to 46%The rising stock price of a company does not mean that the business is strong. And a falling stock price does not mean that the business is...
- Focus beyond noise and uncertainty of tariff war: 6 Large-cap stocks with an upside potential of up to 42%The coming week will see statements from different parts of the world on the tariff war unleashed by US President Trump. And these will mak...
- Pharma stocks: With headwinds of uncertainty over, will they outperform? 7 stocks with an upside potential of up to 43%When it is Trump, logic usually flies out of the window. There is, indeed, little that is logical about the reciprocal tariffs he has annou...
- Pharma: Stay bullish, but hedge to avoid mistake of selling due to deadline. 7 stocks with upside potential of up to 50%While Democrats are better known to push for lower drug prices in the US, in recent times even Republicans are talking about keeping the co...
- Manufacturing issues led drug makers Glenmark, Sun Pharma, Dr Reddy's to recall products in USAs per the US health regulator, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may caus...
- New toxic drug impurities detected in some heart pills in USThe impurities were found in blood pressure drugs which have been recalled in Canada as well as Europe earlier this year. U.S. officials he...
- Blood-pressure drugs are in the crosshairs of COVID-19 researchResearchers agree that the life-saving drugs affect the same pathways that the novel coronavirus takes to enter the lungs and heart. They d...
- Aurobindo recalls hypertensive drug in US citing cancer riskScieGen Pharmaceuticals has initiated recall of the finished Irbesartan drug from the market, a separate notification by the FDA said.
- Unichem Lab gets USFDA nod for hypertension drugThe company has received final abbreviated new drug application (ANDA) approval from the US Food and Drug Administration (USFDA).
- Heart disease drugs may help treat EbolaEndothelial cell dysfunction has been a central feature of human Ebola virus disease leading to severe fluid and mineral losses.
- Sensex advances 200 points; top 14 stocks in focusNifty also managed to gain over 50 points to reclaim its crucial psychological level of 8800, supported by gains in power, oil & gas, banks...
- Jubilant Life gets USFDA nod for hypertension, allergies drugsJubilant Life Sciences had a total of 781 filings for formulations of which 333 have been approved in various regions globally as on Decemb...
- Divi's Labs: Short term pain, long term positiveThe stock of drug firm Divi's Labs has corrected 12% since the company announced its March quarter at the beginning of this week.
- Unichem Labs gets USFDA approval for hypertension drugIrbesartan tablets are indicated for the treatment of hypertension and are therapeutically equivalent to Sanofi Aventis' Avapro tablets, it...
- Lupin gets US FDA nod for generic Avapro tabletsPharma major Lupin today said its subsidiary, Lupin Pharmaceuticals, has received approval for its Irbesartan tablets from US Food and Drug...
- Zydus Cadila gets USFDA nod for hypertension drug Isbesartan tabletDrug firm Zydus Cadila has received the US health regulator's approval to market Isbesartan tablets, used in treating hypertension, in the ...
Load More
